Esperion Therapeutics, Inc.: operating_income
| Value | {"amount": -10164371, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2011-01-01 – 2011-12-31 |
| Status | current |
| Entity | Esperion Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:06:43.494534+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e8a57208-3985-49ed-912d-5d24dd41aa48
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001047469-14-002320Retrieved: 2026-08-19T14:06:43.494534+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001434868/operating-income/2011-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e8a57208-3985-49ed-912d-5d24dd41aa48
History
- no predecessors — first report